Daré Bioscience, Inc. DARE

Set alert

Price alert · DARE

All alert types
0.65 USD -0.01 -0.76%

As of Nov 3, 10:03 AM ET

Bid
0.65 × 2
Ask
0.66 × 10
0.64 Day range 0.6533
0.625 52-week range 3.78
YTD
-66.32%
1 year
-66.15%
Open
0.6431
Prev close
0.655
Mkt cap
12.78M
Vol
20.10K
Avg vol
506.93K
EPS
-0.71
P/E
0.00
Div yield
0.00%
More statistics
Low
0.64
High
0.6533
Forward P/E
-2.35
Beta
1.34
Short ratio
0.64
Inst. own
7.59%
Dividend
0.00
Ex-div date
50-d avg
3.53
200-d avg
4.07
1y target
21.33

MAX chart

Chart tools
Interval

Events in this range
  • Jul 1, 2024Split: 1 for 12
Signals (33)
NameDateAgo
SMA: BearishJul 1, 20264 months ago
SMA: BullishApr 1, 20267 months ago
MACD: Buy SignalMay 1, 20242 years ago
MACD: Sell SignalAug 1, 20233 years ago
SMA: BearishFeb 1, 20233 years ago
SMA: BullishJan 1, 20233 years ago
MACD: Buy SignalJan 1, 20233 years ago
MACD: Sell SignalSep 1, 20224 years ago
SMA: BearishApr 1, 20224 years ago
SMA: BearishJan 1, 20224 years ago
SMA: BullishNov 1, 20215 years ago
SMA: BearishSep 1, 20215 years ago
SMA: BullishAug 1, 20215 years ago
SMA: BearishJul 1, 20215 years ago
SMA: BullishJun 1, 20215 years ago
SMA: BearishMay 1, 20215 years ago
SMA: BullishNov 1, 20206 years ago
SMA: BullishNov 1, 20206 years ago
SMA: BearishOct 1, 20206 years ago
SMA: BearishSep 1, 20206 years ago

Newest 20 of 33.

Analyst view

Consensus: buy

Buy
Price target (mean) 21.33 +3182.1% upside
Target (low)
12.00
Target (mean)
21.33
Target (high)
39.00
Ratings (0m) 4 3 buy · 1 hold · 0 sell
  • Strong buy1
  • Buy2
  • Hold1
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 4
  • 1 month ago 4
  • 2 months ago 4

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

DARE analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.63333-0.80 – -0.52-0.72+12.0%1.00M-44.7%3
Next quarter-0.65-0.76 – -0.54-0.84+22.6%0-100.0%2
Current year-0.46-0.63 – -0.34-4.20+89.0%1.05M-62.4%3
Next year-2.01-2.38 – -1.42-0.46-337.7%2.45M+132.4%3

Upgrades and downgrades

The latest rating changes

DARE analyst upgrades and downgrades
DateFirmActionFromTo
Dec 17, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 15, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 24, 2024HC Wainwright & Co.ReiteratedBuyBuy
Aug 16, 2024Jones TradingMaintainedBuyBuy
Aug 14, 2024Maxim GroupDowngradeBuyHold
May 15, 2024HC Wainwright & Co.ReiteratedBuyBuy
May 15, 2024Brookline CapitalUpgradeHoldBuy
May 1, 2024HC Wainwright & Co.ReiteratedBuyBuy
Apr 17, 2024Brookline CapitalDowngradeBuyHold
Apr 1, 2024HC Wainwright & Co.ReiteratedBuyBuy
Nov 10, 2023HC Wainwright & Co.MaintainedBuyBuy
Aug 11, 2023HC Wainwright & Co.ReiteratedBuyBuy
Jul 13, 2023HC Wainwright & Co.ReiteratedBuyBuy
Jun 6, 2023HC Wainwright & Co.Reiterated—Buy
May 22, 2023HC Wainwright & Co.ReiteratedBuyBuy
May 12, 2023HC Wainwright & Co.ReiteratedBuyBuy
Mar 31, 2023HC Wainwright & Co.Reiterated—Buy
Dec 13, 2022HC Wainwright & Co.Maintained—Buy
Dec 1, 2022JonesTradingInitiated—Buy
Apr 1, 2022HC Wainwright & Co.Maintained—Buy
Jun 30, 2021Roth CapitalMaintained—Buy
Dec 18, 2020HC Wainwright & Co.Initiated—Buy
Apr 28, 2020Brookline CapitalInitiated—Buy
Aug 17, 2018Maxim GroupInitiated—Buy